Merci d'essayer une autre recherche
Nom | Age | Depuis | Titre |
---|---|---|---|
Masayoshi Takeda | - | 2022 | GM, Head of Finance & Accounting Department and Full-Time Audit & Supervisory Board Member |
Naoyuki Mochida | - | 1999 | President & Representative Director |
Kyosuke Wagai | - | 2016 | Outside Audit & Supervisory Board Member |
Keiichi Sagisaka | - | 2010 | Senior Executive Managing Officer of Pharmaceutical Business & Healthcare and Director |
Tomoo Kugisawa | - | 2012 | Independent Outside Director |
Kiyoshi Mizuguchi | - | 2015 | Exec Managing Officer of Research & Development, Supervisor of Pharmaceutical Plant and Director |
Yutaka Kawakami | - | 2019 | Executive Managing Officer, Executive Officer, Head of RA, QA & PV and Executive Director |
Junichi Sakaki | - | 2014 | Senior Exec Managing Officer of Business Development, Supervisor of Biomaterials Business & Director |
Yoshiharu Hashimoto | - | 2019 | Full-Time Audit & Supervisory Board Member |
Yoshifumi Miyata | - | 2021 | Outside Audit & Supervisory Board Member |
Nana Otsuki | - | 2021 | Independent Outside Director |
Shigeaki Yoshikawa | - | 2023 | Independent Outside Director |
Akiko Suzuki | - | 2019 | Outside Audit & Supervisory Board Member |
Tomoaki Sonoda | - | 2022 | Independent Outside Director |
Motoi Mitsuishi | - | 2023 | Member of the Board & Executive Managing Officer |
Chu Sakata | - | 2011 | Senior EVP & Representative Director |
Voulez-vous vraiment bloquer %USER_NAME% ?
Si vous continuez, vous et %USER_NAME% ne verrez plus vos publications Investing.com mutuelles.
%USER_NAME% a bien été ajouté à votre Liste d’utilisateurs bloqués
Vous venez de débloquer cette personne et devrez attendre 48 heures avant de la bloquer de nouveau.
Je souhaite signaler ce commentaire comme:
Merci
Le commentaire signalé sera révisé par nos modérateurs